New shot aims to block deadly rabies virus
NCT ID NCT07445815
Summary
This study is testing a new lab-made antibody injection designed to prevent rabies infection after exposure. It will involve 200 healthy adults to see if the injection is safe and how well it triggers an immune response against the rabies virus, comparing it to the current standard treatment. The goal is to find a potentially better option for preventing this fatal disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lanzhou Institute of Biological Products Co., Ltd.
Lanzhou, Gansu, 730000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.